In the News
John Shakow comments on the recent ruling in the Genesis case that could potentially expand 340B-eligible prescriptions
November 7, 2023
| 340B Report
Featured Lawyers:

Go to the article

Explore King & Spalding
a blue and green background
Capabilities
Special Matters & Government Investigations
a blue and green background
Capabilities
FDA & Life Sciences